The Impact of Antimicrobial Resistance in Cystic Fibrosis

Area of Science:

• Global Health
• Infectious Diseases
• Genetics

Background:

• Antimicrobial resistance (AMR) is a growing global health crisis, projected to cause widespread mortality.
• Individuals with compromised health, including those with neoplastic disease, on immunosuppressive therapy, or with rare diseases like cystic fibrosis (CF), are disproportionately affected by AMR.
• Cystic fibrosis (CF) is a genetic disorder affecting the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) protein, leading to severe respiratory and multi-organ complications.

Purpose of the Study:

• To examine the intricate relationship between antimicrobial resistance (AMR) and climate dynamics.
• To highlight the specific challenges posed by AMR to individuals with cystic fibrosis (CF).
• To review methodologies for AMR measurement and its global impact, focusing on CF airway microbiology.

Main Methods:

• Literature review and synthesis of existing research on AMR, climate dynamics, and cystic fibrosis.
• Analysis of studies detailing AMR measurement techniques and global antibiotic resistance trends.
• Examination of research on microbial communities within the CF airway and their resistance patterns.

Main Results:

• AMR is a significant threat, particularly impacting vulnerable populations like people with CF (PwCF).
• Recurrent pulmonary exacerbations in PwCF are exacerbated by AMR, complicating treatment and disease management.
• Understanding the interplay of climate, AMR, and CF microbiology is crucial for developing effective interventions.

Conclusions:

• There is an urgent need for further research into antimicrobial resistance within the context of cystic fibrosis.
• Addressing AMR in CF requires a multifaceted approach considering environmental factors and specific microbial challenges.
• Enhanced strategies are necessary to combat the rising threat of AMR in vulnerable patient groups.